Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing diabetic nephropathy: recent studies.

Yiming Z Lit1, Timothy Meyer

  • 1Department of Medicine and Nephrology, Stanford University and VA Palo Alto HCS, Stanford, California 93401, USA.

Current Opinion in Nephrology and Hypertension
|February 17, 2006
PubMed
Summary

Aggressively blocking the renin-angiotensin system shows promise for diabetic nephropathy. Further long-term studies are needed to confirm optimal treatment strategies for slowing disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response of Alzheimer's disease-like triple transgenic 3x-Tg mice to experimental migraine evoked by nitroglycerin.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Sucla2 Knock-Out in Skeletal Muscle Yields Mouse Model of Mitochondrial Myopathy With Muscle Type-Specific Phenotypes.

Journal of cachexia, sarcopenia and muscle·2024
Same author

Transvenous phrenic nerve stimulation to treat central sleep apnoea in patients with heart failure may improve sleep, quality of life, and symptoms.

European journal of cardiovascular nursing·2022
Same author

Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study.

Cancer·2021
Same author

Vascular Access for Hemodialysis and Value-Based Purchasing for ESRD.

Journal of the American Society of Nephrology : JASN·2017
Same author

Can twice weekly hemodialysis expand patient access under resource constraints?

Hemodialysis international. International Symposium on Home Hemodialysis·2016

Area of Science:

  • Nephrology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetic nephropathy is a leading cause of chronic kidney disease.
  • Effective management strategies are crucial to slow disease progression.

Purpose of the Study:

  • To review recent studies on improved treatments for diabetic nephropathy.
  • To evaluate the efficacy of different therapeutic approaches.

Main Methods:

  • Literature review of recent clinical studies and trials.
  • Analysis of pharmacological interventions targeting the renin-angiotensin system and other pathways.

Main Results:

  • Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers demonstrate similar renoprotective effects.

Related Experiment Videos

  • Dual blockade of the renin-angiotensin system and aldosterone receptor antagonists show potential benefits.
  • Long-term data on combination therapies and higher single-agent doses are still lacking.
  • Thiazolidinedione hypoglycemic agents are not currently recommended for renal protection.

    • Conclusions:

    • Short-term evidence supports aggressive renin-angiotensin system blockade.
    • Long-term studies are essential to determine optimal treatment durations and combinations.
    • A multifactorial approach combining established interventions is the most effective strategy to retard diabetic nephropathy progression.